
Hill-Rom Holdings, Inc. HRC
Land |
|
IPO-Jahr |
- |
Branche |
Medizinische Instrumente |
Börse |
NYSESPB |
Anteile |
66.6 M |
Marktkapitalisierung |
$ 10.3 B |
EBITDA (LTM) |
$ 99.2 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
electroCore
ECOR
|
$ 11.42 | 2.46 % | $ 96.9 K | Nasdaq Global Select Market | ||
|
Alcon
ALC
|
$ 65.39 | 0.02 % | $ 32.3 B | NYSE | ||
|
Glaukos Corporation
GKOS
|
$ 153.49 | 0.19 % | $ 8.78 B | NYSE,SPB | ||
|
Haemonetics Corporation
HAE
|
$ 106.82 | 0.01 % | $ 5.04 B | NYSE,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 8.05 | 1.64 % | $ 357 M | Nasdaq Global Market | ||
|
InfuSystem Holdings
INFU
|
$ 12.7 | 2.26 % | $ 262 M | NYSE American | ||
|
iRhythm Technologies
IRTC
|
$ 111.75 | 1.1 % | $ 3.58 B | Nasdaq Global Select Market,SPB | ||
|
Intuitive Surgical
ISRG
|
$ 398.3 | 0.06 % | $ 142 B | Nasdaq Global Select Market,SPB | ||
|
AngioDynamics
ANGO
|
$ 15.51 | 0.26 % | $ 644 M | Nasdaq Global Select Market | ||
|
Repro Med Systems
KRMD
|
$ 3.27 | 2.42 % | $ 151 M | Nasdaq Capital Market | ||
|
LeMaitre Vascular
LMAT
|
$ 80.58 | 0.12 % | $ 1.82 B | Nasdaq Global Market,SPB | ||
|
Microbot Medical
MBOT
|
$ 1.31 | 0.36 % | $ 60 M | Nasdaq Global Select Market | ||
|
Merit Medical Systems
MMSI
|
$ 87.07 | 0.1 % | $ 5.15 B | Nasdaq Global Select Market,SPB | ||
|
Nephros
NEPH
|
$ 4.29 | 2.88 % | $ 45.5 M | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 23.82 | 0.41 % | $ 4 B | NYSE | ||
|
OraSure Technologies
OSUR
|
$ 3.99 | 8.13 % | $ 293 M | Nasdaq Global Select Market,SPB | ||
|
Pro-Dex
PDEX
|
$ 71.94 | 0.12 % | $ 232 B | Nasdaq Global Select Market | ||
|
Pulse Biosciences
PLSE
|
$ 51.98 | 0.25 % | $ 3.5 B | Nasdaq Global Select Market | ||
|
Repligen Corporation
RGEN
|
$ 184.53 | 0.81 % | $ 10.4 M | Nasdaq Global Select Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.7 | 0.36 % | $ 21 M | NYSE American | ||
|
AtriCure
ATRC
|
$ 59.96 | 1.91 % | $ 2.86 B | Nasdaq Global Market,SPB | ||
|
STAAR Surgical Company
STAA
|
$ 19.8 | 1.62 % | $ 981 M | Nasdaq Global Market,SPB | ||
|
STERIS plc
STE
|
$ 209.98 | 0.61 % | $ 20.6 B | NYSE,SPB | ||
|
Stereotaxis
STXS
|
$ 1.32 | 2.94 % | $ 120 M | NYSE American | ||
|
BioLife Solutions
BLFS
|
$ 37.74 | 0.37 % | $ 1.8 B | Nasdaq Global Select Market | ||
|
Baxter International
BAX
|
$ 23.49 | 0.17 % | $ 12.1 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 75.01 | 2.93 % | $ 243 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 375.87 | 1.29 % | $ 27.2 B | NYSE,SPB | ||
|
Becton, Dickinson and Company
BDX
|
$ 182.52 | 0.01 % | $ 52.5 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 9.78 | 0.05 % | $ 1.95 B | Nasdaq Global Select Market,SPB | ||
|
The Cooper Companies
COO
|
$ 56.07 | 1.41 % | $ 11.2 B | NYSE,SPB | ||
|
ICU Medical
ICUI
|
$ 163.32 | 1.45 % | $ 4.02 B | Nasdaq Global Select Market,SPB | ||
|
Milestone Scientific
MLSS
|
$ 0.42 | 4.73 % | $ 34.5 M | NYSE American | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Teleflex Incorporated
TFX
|
$ 121.75 | 0.08 % | $ 5.43 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 222.3 | 0.15 % | $ 32.3 B | NYSE,SPB | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Masimo Corporation
MASI
|
- | - | $ 9.59 B | Nasdaq Global Select Market,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market |